Evaluation of the SARC-F Score as a Screening Tool for Undernutrition in a

Status Recruiting

Clinical Trial Summary

To study the relationship between sarcopenia and undernutrition in adult patients over 70 years of age, and at the same time to define a threshold value for the predictive SARC-F score of undernutrition.

Hypothesis : the SARC-F score is correlated with malnutrition defined according to the following HAS criteria :

Moderate denutrition Severe denutrition

Clinical Trial Description

The geriatric population is a population at risk, given the frequent and numerous comorbidities present. Undernutrition is one of these, which is frequently associated with sarcopenia, that is, a decrease in muscle strength. Its screening must be early to avoid complications (osteoporosis, fractures, infections ...) and given the cost it generates for society. However, the detection of undernutrition can sometimes be time-consuming and its criteria in default, such as in the presence of edema or obesity, for example. There is a score, the SARC-F, which allows to detect sarcopenia from a result greater than or equal to 4, but which does not allow direct detection of undernutrition.

The primary objective is to evaluate the SARC-F score as a screening tool for undernutrition in a geriatric population, secondary objectives being to find a threshold value at this score, and also to estimate a prevalence of undernutrition in this population.

It will be a cross-sectional exploratory study to evaluate a diagnostic tool, the SARC-F score, with comparison between cases and controls.

The study will be conducted in a single center, a geriatric short-stay service. Participation in the study will be offered to any patient admitted to the geriatric ward, those who meet the inclusion criteria and do not have exclusion criteria will have to complete the SARC-F questionnaire during their stay, and to do the handgrip test and impedancemetry performed by a third party. Biological data (albumin, pre-albumin and C-Reactive Protein) and anthropometric data will be collected and analyzed to determine if the patient is malnourished or not, and the results of SARC-F will be compared between these 2 groups. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03553147
Study type	Interventional
Source	University Hospital, Clermont-Ferrand
Contact	Patrick LACARIN
Phone	0473751195
Email	placarin@chu-clermontferrand.fr
Status	Recruiting
Phase	N/A
Start date	May 31, 2018
Completion date	September 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06287502` - Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis	N/A
Recruiting	`NCT05063279` - RELIEF - Resistance Training for Life	N/A
Completed	`NCT03644030` - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Recruiting	`NCT06143592` - Inspiratory Muscle Training on Balance, Falls and Diaphragm Thickness in the Elderly	N/A
Terminated	`NCT04350762` - Nutritional Supplementation in the Elderly With Weight Loss	N/A
Enrolling by invitation	`NCT05953116` - Managing the Nutritional Needs of Older Filipino With Due Attention to Protein Nutrition and Functional Health Study	N/A
Recruiting	`NCT04028206` - Resistance Exercise or Vibration With HMB for Sarcopenia	N/A
Enrolling by invitation	`NCT03297632` - Improving Muscle Strength, Mass and Physical Function in Older Adults	N/A
Completed	`NCT04015479` - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults	N/A
Completed	`NCT03234920` - Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation	N/A
Recruiting	`NCT03998202` - Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Recruiting	`NCT04717869` - Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
Completed	`NCT05497687` - Strength-building Lifestyle-integrated Intervention	N/A
Completed	`NCT03119610` - The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity	Phase 1/Phase 2
Recruiting	`NCT05711095` - The Anabolic Properties of Fortified Plant-based Protein in Older People	N/A
Recruiting	`NCT05008770` - Trial in Elderly With Musculoskeletal Problems Due to Underlying Sarcopenia - Faeces to Unravel Gut and Inflammation Translationally
Not yet recruiting	`NCT05860556` - Sustainable Eating Pattern to Limit Malnutrition in Older Adults
Recruiting	`NCT04545268` - Prehabilitation for Cardiac Surgery in Patients With Reduced Exercise Tolerance	N/A
Recruiting	`NCT04522609` - Electrostimulation of Skeletal Muscles in Patients Listed for a Heart Transplant	N/A
Recruiting	`NCT03160326` - The QUALITY Vets Project: Muscle Quality and Kidney Disease

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of the SARC-F Score as a Screening Tool for Undernutrition in a Geriatric Population — GERIASARC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms